Evaluating the effects of honey bee (Apis mellifera L.) venom on the expression of insulin sensitivity and inflammation-related genes in co-culture of adipocytes and macrophages

다국어 초록 (Multilingual Abstract)

Obese adipose tissue is characterized by adipocyte hypertrophy and a massive macrophage infiltration. The interaction between macrophages with mature adipocytes releases pro-inflammatory cytokines. This chronic inflammatory state can contribute to obesity-related complications, such as insulin resistance, type 2 diabetes and cardiovascular disease. Therefore, we can attempt to prevent and treat obesity-related diseases by inhibiting macrophage infiltration and blocking their interaction with adipocytes. Honey bee (Apis mellifera) venom (BV) has been reported to have anti-inflammatory effects. Although BV is used to treat chronic inflammatory diseases, few studies have addressed its use in obesity-associated inflammation. This study examines the inhibitory effects of BV on lipid accumulation in differentiating preadipocytes, inflammation, and insulin resistance in macrophages and adipocyte-macrophage co-culture system. We treated 3 T3-L1 preadipocytes with BV during differentiation. We later measured lipid accumulation and gene expression of master adipogenic transcription factors. After RAW264.7 and 3 T3-L1 cells were pretreated with BV, RAW264.7 cells were activated with LPS or co-cultured with pretreated 3 T3-L1 cells. Gene expression of pro-inflammatory cytokines and insulin sensitizing genes was measured in these cells. BV inhibited lipid accumulation and C/EBPα and PPARγ gene expression during intermediate and late 3 T3-L1 cell differentiation. BV also suppressed gene expression of pro-inflammatory cytokines (COX-2, iNOS, MCP-1, TNF-α, IL-1β and IL-6) in LPS-stimulated macrophages, and in co-culture of 3 T3-L1 adipocytes and RAW264.7 macrophages. However, adiponectin and GLUT-4 expression were both significantly increased by BV in co-culture. These findings demonstrate that BV attenuates adipocyte hypertrophy and improves obesity-related inflammation and insulin resistance in obese adipose tissue.

참고문헌 (Reference)

1 Ten Klooster JP, "Type 2 diabetes-related proteins derived from an in vitro model of inflamed fat tissue" 644 : 81-92, 2018

2 Kwon YB, "The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats" 71 : 191-204, 2002

3 Lee YH, "The evolving role of inflammation in obesity and the metabolic syndrome" 5 : 70-75, 2005

4 Kim SJ, "The Protective Effect of Apamin on LPS/Fat-Induced Atherosclerotic Mice" 2012 : 305454-, 2012

5 Tontonoz P, "Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor" 79 : 1147-1156, 1994

6 Ahn YJ, "Safety of essential bee venom pharmacopuncture as assessed in a randomized controlled double-blind trial" 194 : 774-780, 2016

7 Mazur-Bialy AI, "Riboflavin Reduces Pro-Inflammatory Activation of Adipocyte-Macrophage Coculture. Potential Application of Vitamin B2 Enrichment for Attenuation of Insulin Resistance and Metabolic Syndrome Development" 21 : E1724-, 2016

8 Weisberg SP, "Obesity is associated with macrophage accumulation in adipose tissue" 112 : 1796-1808, 2003

9 Jang HS, "Microarray analysis of gene expression profiles in response to treatment with bee venom in lipopolysaccharide activated RAW 264.7 cells" 121 : 213-220, 2009

10 Kim SJ, "Melittin inhibits atherosclerosis in LPS/high-fat treated mice through atheroprotective actions" 18 : 1117-1126, 2011

11 Park HJ, "JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin" 5 : 7-, 2008

12 An HJ, "Inhibitory effects of bee venom on Propionibacterium acnes-induced inflammatory skin disease in an animal model" 34 : 1341-1348, 2014

13 Hotamisligil GS, "Inflammation and metabolic disorders" 444 : 860-867, 2006

14 Jo J, "Hypertrophy and/or Hyperplasia: Dynamics of Adipose Tissue Growth" 5 : e1000324-, 2009

15 Jang HS, "Effects of bee venom on the pro-inflammatory responses in RAW264.7 macrophage cell line" 99 : 157-160, 2005

16 Zhang S, "Bee venom therapy : Potential mechanisms and therapeutic applications" 148 : 64-73, 2018

17 Hozzein WN, "Bee venom improves diabetic wound healing by protecting functional macrophages from apoptosis and enhancing Nrf2, Ang-1 and Tie-2 signaling" 103 : 322-335, 2018

18 Wehbe R, "Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests" 24 : E2997-, 2019

19 Cheon SY, "Bee Venom Suppresses the Differentiation of Preadipocytes and High Fat Diet-Induced Obesity by Inhibiting Adipogenesis" 10 : 9-, 2018

20 Ham HJ, "Bee Venom Soluble Phospholipase A2 Exerts Neuroprotective Effects in a Lipopolysaccharide-Induced Mouse Model of Alzheimer’s Disease via Inhibition of Nuclear Factor-Kappa B" 11 : 287-, 2019

21 정창희, "Bee Venom Decreases LPS-Induced Inflammatory Responses in Bovine Mammary Epithelial Cells" 한국미생물·생명공학회 27 (27): 1827-1836, 2017

22 Boman HG, "Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids" 259 : 103-106, 1989

23 Park HJ, "Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit" 50 : 3504-3515, 2004

24 Jo M, "Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway" 258 : 72-81, 2012

25 Lee JD, "An Overview of Bee Venom Acupuncture in the Treatment of Arthritis" 2 : 79-84, 2005

26 Suganami T, "Adipose tissue macrophages : their role in adipose tissue remodeling" 88 : 33-39, 2010

27 Ntambi JM, "Adipocyte differentiation and gene expression" 130 : 3122S-3126S, 2000

28 Reilly SM, "Adapting to obesity with adipose tissue inflammation" 13 : 633-643, 2017

29 Verboven K, "Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans" 8 : 4677-, 2018

30 Lee YH, "Abdominal obesity and cardiovascular disease risk : the emerging role of the adipocyte" 27 : 2-10, 2007

31 Kuri-Harcuch W, "A cellular perspective of adipogenesis transcriptional regulation" 234 : 1111-1129, 2019